Acute gastrointestinal bleeding after percutaneous coronary intervention

References

• Mehta SR, Cannon CP, Fox KA et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA293(23), 2908–2917 (2005).
   PubMed Web of Science ®Google Scholar
• Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation116(7), e148–e304 (2007).
   PubMed Web of Science ®Google Scholar
• Antman EM, Hand M, Armstrong PW et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee. Circulation117(2), 296–329 (2008).
   PubMed Web of Science ®Google Scholar
• King SB III, Smith SC Jr, Hirshfeld JW Jr et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 Writing Committee. Circulation117(2), 261–295 (2008).
   PubMed Web of Science ®Google Scholar
• Steinhubl SR, Kastrati A, Berger PB. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. Am. Heart J.154(1), 3–11 (2007).
   PubMed Web of Science ®Google Scholar
• Chesebro JH, Knatterud G, Roberts R et al. Thrombolysis in myocardial infarction (TIMI) trial, Phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation76(1), 142–154 (1987).
   PubMed Web of Science ®Google Scholar
• No authors listed. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N. Engl. J. Med.329(10), 673–682 (1993).
   PubMed Web of Science ®Google Scholar
• Chin MWS, Yong G, Bulsara M, Rankin J, Forbes G. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case–control study. Am. J. Gastroenterol.102(11), 2411–2416 (2007).
   PubMed Web of Science ®Google Scholar
• Ergelen M, Uyarel H, Soylu O et al. Gastrointestinal bleeding in patients undergoing primary angioplasty for acute myocardial infarction: incidence, risk factors and prognosis. Türk Kardiyoloji Derneği Arşivi38(2), 101–106 (2010).
   PubMedGoogle Scholar
• Germing A, Bojara W, Lawo T et al. Bleeding complications associated with glycoprotein IIb/IIIa inhibitors in patients 80 years of age and older undergoing percutaneous coronary intervention. Exp. Clin. Cardiol.15(3), e57–e60 (2010).
   Google Scholar
• Ko D, Yun L, Wijeysundera H et al. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years. Circulation Cardiovasc. Intervent.3(2), 140–147 (2010).
   PubMed Web of Science ®Google Scholar
• Mehta S, Frutkin A, Lindsey J et al. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circulation Cardiovasc. Intervent.2(3), 222–229 (2009).
   PubMed Web of Science ®Google Scholar
• Overgaard C, Ivanov J, Seidelin P, Todorov M, Mackie K, Dzavk V. Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention. Am. Heart J.156(1), 120–124 (2008).
   PubMed Web of Science ®Google Scholar
• Toyokawa T, Inaba T, Ishikawa S, Nakatsu M, Ando M, Tomoda J. Investigation of upper gastrointestinal bleeding after implantation of drug-eluting stents; prospective cohort study. Scand. J. Gastroenterol.45(9), 1097–1100 (2010).
   PubMed Web of Science ®Google Scholar
• Yasuda H, Yamada M, Sawada S et al. Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting. Intern. Med.48(19), 1725–1730 (2009).
   PubMed Web of Science ®Google Scholar
• Shalev A, Zahger D, Novack V et al. Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes. Int. J. Cardiol. doi:10.1016/j.ijcard.2010.12.081 (2011) (Epub ahead of print).
   Google Scholar
• Abbas A, Brodie B, Dixon S et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am. J. Cardiol.96(2), 173–176 (2005).
   PubMed Web of Science ®Google Scholar
• Aronow H, Steinhubl S, Brennan D, Berger P, Topol E. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am. Heart J.157(2), 369–374 (2009).
   PubMed Web of Science ®Google Scholar
• Bagur R, Bertrand OF, Rodes-Cabau J et al. Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome. Am. J. Cardiol.104(5), 624–629 (2009).
   PubMedGoogle Scholar
• Cayla G, Silvain J, Barthelemy O et al. Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD Study. Heart97(11), 887–891 (2011).
   PubMedGoogle Scholar
• Lincoff AM, Bittl JA, Harrington RA et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA289(7), 853–863 (2003).
   PubMed Web of Science ®Google Scholar
• Nikolsky E, Stone GW, Kirtane AJ et al. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J. Am. Coll. Cardiol.54(14), 1293–1302 (2009).
   PubMed Web of Science ®Google Scholar
• Gaglia M, Torguson R, Gonzalez M et al. Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention. Am. J. Cardiol.106(8), 1069–1074 (2010).
   PubMedGoogle Scholar
• Steinberg DH, Shah P, Kinnaird T et al. Bleeding risk and outcomes of bivalirudin versus glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Am. J. Cardiol.102(2), 160–164 (2008).
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Fox KA, Hacke W et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N. Engl. J. Med.354(16), 1706–1717 (2006).
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med.345(7), 494–502 (2001).
   PubMed Web of Science ®Google Scholar
• Barkun AN, Bardou M, Kuipers EJ et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann. Intern. Med.152(2), 101–113 (2010).
   PubMed Web of Science ®Google Scholar
• Lemesle G, Maluenda G, Bonello L et al. Dosing strategies for antiplatelet therapy in percutaneous coronary intervention. Hosp. Pract. (Minneap.)38(2), 50–58 (2010).
   PubMedGoogle Scholar
• Manoukian SV, Voeltz MD, Eikelboom J. Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk. Clin. Cardiol.30(10 Suppl. 2), II24–II34 (2007).
   PubMed Web of Science ®Google Scholar
• Saucedo JF. Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention. J. Thromb. Thrombolysis30(2), 200–209 (2010).
   PubMedGoogle Scholar
• Nikolsky E, Aymong ED, Halkin A et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J. Am. Coll. Cardiol.44(3), 547–553 (2004).
   PubMed Web of Science ®Google Scholar
• Nikolsky E, Mehran R, Aymong ED et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am. J. Cardiol.94(8), 1023–1027 (2004).
   PubMed Web of Science ®Google Scholar
• Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N. Engl. J. Med.345(17), 1230–1236 (2001).
   PubMed Web of Science ®Google Scholar
• Rao SV, Jollis JG, Harrington RA et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA292(13), 1555–1562 (2004).
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, Giugliano RP et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation111(16), 2042–2049 (2005).
   PubMed Web of Science ®Google Scholar
• Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J. Thromb. Thrombolysis21(2), 167–174 (2006).
   PubMed Web of Science ®Google Scholar
• Hansen ML, Sorensen R, Clausen MT et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch. Intern. Med.170(16), 1433–1441 (2010).
   PubMed Web of Science ®Google Scholar
• Oyetayo O, Talbert R. Proton pump inhibitors and clopidogrel: is it a significant drug interaction? Expert Opin. Drug Safety9(4), 593–602 (2010).
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Scheiman J, Abraham NS et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation118(18), 1894–1909 (2008).
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Cryer BL, Contant CF et al. Clopidogrel with or without omeprazole in coronary artery disease. N. Engl. J. Med.363(20), 1909–1917 (2010).
   PubMed Web of Science ®Google Scholar
• Abraham NS, Hlatky MA, Antman EM et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation122(24), 2619–2633 (2010).
   PubMed Web of Science ®Google Scholar
• Charlot M, Grove EL, Hansen PR et al. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. BMJ342, d2690 (2011).
   PubMed Web of Science ®Google Scholar
• Richy F, Bruyere O, Ethgen O et al. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann. Rheum. Dis.63(7), 759–766 (2004).
   PubMed Web of Science ®Google Scholar
• Taha AS, McCloskey C, Prasad R, Bezlyak V. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a Phase 3, randomised, double-blind, placebo-controlled trial. Lancet374(9684), 119–125 (2009).
   PubMed Web of Science ®Google Scholar
• Greenspoon J, Barkun A. The pharmacological therapy of non-variceal upper gastrointestinal bleeding. Gastroenterol. Clin. North Am.39(3), 419–432 (2010).
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, McCabe CH et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med.357(20), 2001–2015 (2007).
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med.361(11), 1045–1057 (2009).
   PubMed Web of Science ®Google Scholar
• Hiew C, Duggan A, Malmanche TD et al. Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention. Intern. Med. J. doi:10.1111/j.1445-5994.2010.02260.x (2010) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet1(8390), 1311–1315 (1984).
   PubMed Web of Science ®Google Scholar
• O’Connor A, Gisbert JP, McNamara D, O’Morain C. Treatment of Helicobacter pylori infection 2010. Helicobacter15(Suppl. 1), 46–52 (2010).
   PubMed Web of Science ®Google Scholar
• Consensus conference. Perioperative red blood cell transfusion. JAMA260(18), 2700–2703 (1988).
   PubMed Web of Science ®Google Scholar
• Baradarian R, Ramdhaney S, Chapalamadugu R et al. Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am. J. Gastroenterol.99(4), 619–622 (2004).
   PubMed Web of Science ®Google Scholar
• Cappell MS, Iacovone FM Jr. Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction. Am. J. Med.106(1), 29–35 (1999).
   PubMed Web of Science ®Google Scholar
• Elmunzer BJ, Young SD, Inadomi JM, Schoenfeld P, Laine L. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am. J. Gastroenterol.103(10), 2625–2632; quiz 33 (2008).
   PubMed Web of Science ®Google Scholar
• Sung JY, Chung SC, Low JM et al. Systemic absorption of epinephrine after endoscopic submucosal injection in patients with bleeding peptic ulcers. Gastrointest. Endosc.39(1), 20–22 (1993).
   PubMed Web of Science ®Google Scholar
• van Werkum JW, Heestermans AA, Zomer AC et al. Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry. J. Am. Coll. Cardiol.53(16), 1399–1409 (2009).
   PubMed Web of Science ®Google Scholar
• Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA293(17), 2126–2130 (2005).
   PubMed Web of Science ®Google Scholar
• van Werkum JW, Heestermans AA, de Korte FI et al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation119(6), 828–834 (2009).
   PubMed Web of Science ®Google Scholar
• Yeo KK, Mahmud E, Armstrong EJ et al. Contemporary clinical characteristics, treatment, and outcomes of angiographically confirmed coronary stent thrombosis: results from a multicenter California registry. Catheter. Cardiovasc. Interv. doi:10.1002/ccd.23011 (2011) (Epub ahead of print).
   Google Scholar
• Jeremias A, Sylvia B, Bridges J et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation109(16), 1930–1932 (2004).
   PubMed Web of Science ®Google Scholar
• Park DW, Park SW, Park KH et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am. J. Cardiol.98(3), 352–356 (2006).
   PubMed Web of Science ®Google Scholar
• Spertus JA, Kettelkamp R, Vance C et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation113(24), 2803–2809 (2006).
   PubMed Web of Science ®Google Scholar
• Eisenberg MJ, Richard PR, Libersan D, Filion KB. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation119(12), 1634–1642 (2009).
   PubMed Web of Science ®Google Scholar
• Rolfe S, Papadopoulos S, Cabral KP. Controversies of anticoagulation reversal in life-threatening bleeds. J. Pharm. Pract.23(3), 217–225 (2010).
   PubMedGoogle Scholar
• Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus. Med. Rev.21(1), 37–48 (2007).
   PubMed Web of Science ®Google Scholar
• Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126(Suppl. 3), S234–S264 (2004).
   PubMed Web of Science ®Google Scholar
• Sharis PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann. Intern. Med.129(5), 394–405 (1998).
   PubMed Web of Science ®Google Scholar
• Scharf RE, Rahman MM, Seidel H. The impact and management of acquired platelet dysfunction. Hamostaseologie31(1), 28–40 (2011).
   PubMed Web of Science ®Google Scholar
• Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation116(17), 1971–1996 (2007).
   PubMed Web of Science ®Google Scholar
• Shah KB, Kleinman BS, Sami H, Patel J, Rao TL. Reevaluation of perioperative myocardial infarction in patients with prior myocardial infarction undergoing noncardiac operations. Anesth. Analg.71(3), 231–235 (1990).
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz JE. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst. Rev.2, CD004062 (2004).
   PubMedGoogle Scholar
• Strate LL, Naumann CR. The role of colonoscopy and radiological procedures in the management of acute lower intestinal bleeding. Clin. Gastroenterol. Hepatol.8(4), 333–343; quiz e44 (2010).
   PubMed Web of Science ®Google Scholar
• Strate LL, Liu YL, Huang ES, Giovannucci EL, Chan AT. Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology140(5), 1427–1433 (2011).
   PubMed Web of Science ®Google Scholar
• Cappell MS. Safety and efficacy of colonoscopy after myocardial infarction: an analysis of 100 study patients and 100 control patients at two tertiary cardiac referral hospitals. Gastrointest. Endosc.60(6), 901–909 (2004).
   PubMed Web of Science ®Google Scholar
• Shiotani A, Honda K, Murao T et al. Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury. Scand. J. Gastroenterol.46(3), 281–286 (2011).
   PubMed Web of Science ®Google Scholar